GLRX5 and melanoma: Analysis of the TCGA-SKCM and GTEx datasets revealed elevated expression of NF2, SUZ39H1, CDC25A, GLRX5, and CISD3 in melanoma tissues, in contrast with the reduced expression of VDR, PPARD, CAMKK2, NT5DC2, and CHP1A (Figure S7A).